Teague et al. showed that culturing tolerant tumor-specific CD8+ T cells in vitro in IL-15 induces proliferation and reverses tolerance enabling effective tumor therapy after adoptive transfer, but gave IL-2 to support T cells in vivo [45]. The gene discussed is IL2; the disease is neoplasm.